The effect of cyclin-dependent kinases inhibitor olomoucine treatment on experimental HSE mice is explored.
Olomoucine can induce a blunted inflammatory response and maintain the blood vessel wall intact in HSE mice.
Olomoucine can improve neurological function and increase survival in HSE mice.